Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • EMPA-REG versus canagliflozin...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
EMPA-REG versus canagliflozin cardiovascular assessment study OUTCOME: A class effect after all?

EMPA-REG versus canagliflozin cardiovascular assessment study OUTCOME: A class effect after all?

Bibliographic Details
Main Author: Kristina Blaslov
Format: Article
Language:English
Published: VBZ 2017-09-01
Series:Endocrine Oncology and Metabolism
Subjects:
EMPA-REG
CANVAS
explanation
ketosis
mortality
heart failure
kidney function
Online Access:http://eom.hdeo.eu/wp-content/uploads/2017/10/vol3-iss3-1Blaslov.pdf
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://eom.hdeo.eu/wp-content/uploads/2017/10/vol3-iss3-1Blaslov.pdf

Similar Items

  • EMPA-REG OUTCOME trial and Canagliflozin Cardiovascular Assessment Study: Looking beyond the obvious
    by: Rishad Ahmed, et al.
    Published: (2017-01-01)
  • Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME
    by: Pierpaolo Pellicori, et al.
    Published: (2020-12-01)
  • THE INTERIM EXPERTS’ COUNCIL RESOLUTION ON THE EMPA-REG OUTCOME TRIAL ISSUES
    by: M. V. Shestakova, et al.
    Published: (2016-05-01)
  • The interim experts’ counsil resolution on the EMPA-REG OUTCOME trial issues
    by: Editorial team Diabetes Mellitus
    Published: (2016-05-01)
  • Resolution of an online meeting of the Volga Federal District experts on the EMPEROR-Reduced trial “A new era in the treatment of patients with HF. From EMPA-REG OUTCOME to EMPEROR-Reduced trial”
    by: S. V. Villevalde, et al.
    Published: (2021-07-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...